Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SRGN |
| Upstream (Parents) |
|---|
| (<<) CD86 → SRGN |
| (<<) HLA-DRA → SRGN |
| (<<) FCER1G → SRGN |
| (<<) SP110 → SRGN |
| Downstream (Children) |
|---|
| SRGN → LYN (>>) |
| SRGN → CCL2 (>>) |
| SRGN → PITPNM3 (>>) |
| SRGN → CD86 (>>) |
| SRGN → IFITM1 (>>) |
| SRGN → DLG5 (>>) |
| SRGN → RNASE1 (>>) |
| SRGN → FBXO16///ZNF395 (>>) |
| SRGN → ARHGEF37 (>>) |
| SRGN → OVOL2 (>>) |
| SRGN → IGSF9 (>>) |
| SRGN → SAT1 (>>) |
| SRGN → IGSF3 (>>) |
| SRGN → ZNF395 (>>) |
| SRGN → DBN1 (>>) |
| SRGN → CXCR4 (>>) |
| SRGN → GLRX (>>) |
| SRGN → FCER1G (>>) |
| SRGN → CLEC7A (>>) |
| SRGN → ALOX5AP (>>) |
| SRGN → SP110 (>>) |
| SRGN → MPZL3 (>>) |
| SRGN → RAC2 (>>) |
